← Opportunities

Kissick Family Foundation FTD Grant Program, 2026–2027

Funder
Kissick Family Foundation · FTD Grant Program ✅ Proven payer
Type / status
other · closed
Amount
500,000 USD
Deadline
2026-11-04 (past)
“accepting letters of intent now through Wednesday, November 4, 2026”
Ecosystems
Categories
research
Tech stack
Apply
https://sciencephilanthropy.org/funding/requests-for-proposals
Source
https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session
Fit
5% · poor fit · The Venture23 Aleo team works on blockchain and ZK tech, which is entirely unrelated to frontotemporal dementia research.
Trust
91% · model self-report 90% · first seen 2026-09-29 · v1
Verified
2026-11-04 · page still up, no closing language

The Kissick Family Foundation is offering grants for research on frontotemporal dementia (FTD) to accelerate basic discoveries and improve patient outcomes. Researchers studying the fundamental biology of sporadic FTD are encouraged to apply. Applicants must submit a letter of intent by November 4, 2026, with full proposals invited afterward. Funding provides up to $500,000 over two years, including indirect costs.

Eligibility: Researchers studying frontotemporal dementia, particularly the fundamental biology of sporadic forms, are eligible to apply.

Pipeline

Override status:

Funder track record · does Kissick Family Foundation actually pay grants?

✅ Proven payer · 16 grantees found · last payout 2026-10-08 · checked 2026-11-03 · 0 forum reports, 10 web pages read, 3 unverifiable claims dropped

Proven payer: at least 3 named grantees and one payout in the last 90 days. Every grantee below is quoted word for word from its source. When a source does not date a grant, the date is when that page or post was published.

GranteeAmountDateEvidence
Michael Guo, MD, PhD, Michael Haney, PhD, and Hong Xu, PhD—2026-10-08“The Penn team — consisting of three IOA Members, Michael Guo, MD, PhD, Michael Haney, PhD, and Hong Xu, PhD — will receive funding for their project "Decoding somatic genome instability as a driver of selective neuronal ” source
William W. Seeley and Alex Pollen—2026-09-24
page date
“At the University of California, San Francisco, William W. Seeley and Alex Pollen will study neuron-specific vulnerability and the biological processes involved in FTLD-TDP, a major form of frontotemporal degeneration.” source
Michael Guo, Michael Haney and Hong Xu—2026-09-24
page date
“Michael Guo, Michael Haney and Hong Xu at the University of Pennsylvania will investigate how instability in the genomes of individual cells may contribute to the selective loss of neurons seen in FTD.” source
William W. Seeley, MD, and Alex Pollen, PhD, at the University of California, San Francisco—2026-09-24“William W. Seeley, MD, and Alex Pollen, PhD, at the University of California, San Francisco are probing neuron type-specific vulnerability to reveal upstream FTLD-TDP disease mechanisms” source
Clotilde Lagier-Tourenne, MD, PhD, and Liron Bar-Peled, PhD, at Massachusetts General Hospital and Harvard Medical School—2026-09-24“Clotilde Lagier-Tourenne, MD, PhD, and Liron Bar-Peled, PhD, at Massachusetts General Hospital and Harvard Medical School are building a chemical proteomics-based "DrugMap" spanning FTD subtypes” source
Jochen Weishaupt, MD, at Ulm University, working with collaborators at INSERM and the German Cancer Research Center—2026-09-24“Jochen Weishaupt, MD, at Ulm University, working with collaborators at INSERM and the German Cancer Research Center, is investigating genetic mosaicism in FTD pathogenesis” source
Michael Guo, MD, PhD, at the University of Pennsylvania—2026-09-24“Michael Guo, MD, PhD, at the University of Pennsylvania rounds out the group, leading a team decoding somatic genome instability as a driver of selective neuronal vulnerability in FTD” source
10000 Brains Neuro AL Inc$1.0M2026-03-03
page date
“The largest 2024 recipient was 10000 Brains Neuro AL Inc ($1.0M).” source
Ule Jernej, PhD, UK Dementia Research Institute, Kings College London, England, UK—2025-09-15“Co-Investigator: Ule Jernej, PhD, UK Dementia Research Institute, Kings College London, England, UK” source
Beyond Memory—2024-10-08
page date
“Beyond Memory is a dementia awareness campaign that shines a light on less common types of dementia - including frontotemporal, Lewy body, and vascular dementia.” source
The Association for Frontotemporal Degeneration (AFTD)—2024-10-08
page date
“The Association for Frontotemporal Degeneration (AFTD) is the leading organization focused exclusively on the spectrum of FTD disorders.” source
UnRavelled—2024-10-08
page date
“UnRavelled is an award-winning play based on the extraordinary lives of Anne Adams, a brilliant scientist turned painter, and Maurice Ravel, composer of the iconic Boléro. Both were affected by Frontotemporal Dementia (F” source
Barmada Lab—2024-10-08
page date
“The Barmada Lab investigates the foundations of RNA and protein homeostasis in neurons, and how disruptions in these processes lead to neurodegenerative conditions.” source
Kampmann Lab—2024-10-08
page date
“The Kampmann Lab, led by Dr. Martin Kampmann, develops and applies innovative technologies to understand cellular and molecular mechanisms of aging-associated neurodegenerative diseases, and to discover new therapeutic s” source
GENFI—2024-10-08
page date
“Note: The Kissick Family Foundation's grant to GENFI is administered by its strategic partner, the Milken Institute.” source
Lewy Body Dementia Association—2024-10-08
page date
“The Lewy Body Dementia Association (LBDA) is working to change that. As the leading national organization dedicated to improving the lives of individuals and families affected by Lewy body dementia (LBD)” source

Trust breakdown (4/4 checkable facts verified)

SignalWeightResultNote
deadline0.35100%quoted in source
amount0.25100%figure appears in source
apply link0.075100%link in source
funder0.075100%named in source
source quality0.1550%social or search hit
model confidence0.190%model self-report

Fit breakdown (against the ORG_* profile)

SignalWeightResultNote
model fit0.510%model rated 10%
ecosystem overlap0.250%none vs aleo
category overlap0.150%research vs zk, privacy, infra, dev_tooling, security, interoperability
tech overlap0.10%none vs rust, leo, zk

Sources (1)

RoleDocumentFromFetched
primaryKissick Family Foundation FTD Grant Program, 2026–2027: Information Session | Milken InstituteWeb discovery: RFP and grant searches2026-09-29

History (1)

vChangedFields
12026-09-29created

Extracted text

Webinar

# Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session

24 Sep 2026

Topics

[Philanthropy](/topics/philanthropy)

[Grant Management](/taxonomy/philanthropy/grant-management)

[Medical Philanthropy](/topics/philanthropy/medical-philanthropy)

[Medical Research Funding](/topics/philanthropy/medical-philanthropy/medical-research-funding)

[Health](/topics/health)

[Neurological Health](/topics/health/neurological-health)

SHARE

*   [![Linkedin](https://milkeninstitute.org/modules/contrib/social_media/icons/linkedin.svg)](<http://www.linkedin.com/shareArticle?mini=true&url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&title=Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session&source=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session> "Linkedin")
*   [![Twitter](https://milkeninstitute.org/modules/contrib/social_media/icons/twitter.svg)](https://twitter.com/intent/tweet?url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&hashtags=Hashtag "Twitter")
*   [![Facebook](https://milkeninstitute.org/modules/contrib/social_media/icons/facebook_share.svg)](<https://www.facebook.com/share.php?u=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&title=Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session> "Facebook")

[The Kissick Family Foundation](https://kissickfamilyfoundation.org/) [Frontotemporal Dementia (FTD) Grant Program](https://sciencephilanthropy.org/focus-areas/brain-disorders/frontotemporal-dementia/kissick-family-foundation/), in partnership with the Milken Institute [Science Philanthropy Accelerator for Research and Collaboration](https://sciencephilanthropy.org/), is accepting letters of intent now through **Wednesday, November 4, 2026**, for its fourth round of funding. Funded projects will be eligible for up to $500,000 over two years, inclusive of indirect costs.

The grant program aims to accelerate basic discoveries, introduce novel research approaches, and, ultimately, improve patient outcomes for people living with FTD. A broad range of topics is responsive to this call.

An informal informational webinar for interested applicants will be held on **Tuesday, October 13, 2026**, at 11 a.m. US Eastern Time (8 a.m. Pacific Time; 5 p.m. Central European Time). [Attendees must register using this Zoom registration link](https://milkeninstitute-org.zoom.us/meeting/register/pkUaoNaURZujsWbcjIQ-uQ).

The recorded webinar will be hosted on this page after its conclusion.

Interested applicants should apply for the grant program’s fourth round of funding by submitting a letter of intent by November 4, 2026, at 11:59 p.m. US Eastern Time. Please see the full [2026–2027 Request for Proposals](https://sciencephilanthropy.org/funding/requests-for-proposals/) for additional information.

SHARE

*   [![Linkedin](https://milkeninstitute.org/modules/contrib/social_media/icons/linkedin.svg)](<http://www.linkedin.com/shareArticle?mini=true&url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&title=Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session&source=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session> "Linkedin")
*   [![Twitter](https://milkeninstitute.org/modules/contrib/social_media/icons/twitter.svg)](https://twitter.com/intent/tweet?url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&url=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&hashtags=Hashtag "Twitter")
*   [![Facebook](https://milkeninstitute.org/modules/contrib/social_media/icons/facebook_share.svg)](<https://www.facebook.com/share.php?u=https://milkeninstitute.org/content-hub/webinars/kissick-family-foundation-ftd-grant-program-2026-2027-information-session&title=Kissick Family Foundation FTD Grant Program, 2026–2027: Information Session> "Facebook")

## Related Content

*   ![Blue digital brain dissolving into particles on dark background](/sites/default/files/styles/callout_content_425x240/public/2026-09/frontotemporal%20dementia%20metadata.jpg?itok=5YWADwQT)
    
    [RFPs](/content-hub/rfps)
    
    ## [Request for Proposals: Kissick Family Foundation Frontotemporal Dementia Grant Program (2026–2027)](/content-hub/rfps/request-proposals-kissick-family-foundation-frontotemporal-dementia-grant-program-2026-2027)
    
    24 Sep 2026
    
    The Kissick Family Foundation Frontotemporal Dementia (FTD) Grant Program will fund the fourth annual cohort of research studies to understand the fundamental biology of why and how sporadic forms of FTD develop.
    
    [Read Article](/content-hub/rfps/request-proposals-kissick-family-foundation-frontotemporal-dementia-grant-program-2026-2027)
    
*   ![Abstract geometric pattern with overlapping circles and quarter-circles in orange, blue, and navy](/sites/default/files/styles/callout_content_425x240/public/2026-08/Global-Brain-Care-Coalition-landing.jpg?itok=vkNSqRui)
    
    [Report](/content-hub/research-and-reports/reports)
    
    ## [The Global Brain Care Coalition: A Model to Put Brain Science into Action](/content-hub/research-and-reports/reports/global-brain-care-coalition-model-put-brain-science-action)
    
    27 Aug 2026
    
    It takes an average of 17 years for a scientific discovery to travel from the lab to clinical practice. In brain health, that delay has a real cost as the global population ages and more people face conditions such as dementia, stroke, and...
    
    [Read Report](/content-hub/research-and-reports/reports/global-brain-care-coalition-model-put-brain-science-action)
    
    ![Photo of 1](/sites/default/files/2025-05/Samantha%20Schumm.png) ![Photo of 1](/sites/default/files/2025-05/Lillian%20Parr.png) ![Photo of 1](/sites/default/files/2025-02/Aggie%20Stephens.png) ![Photo of 1](/sites/default/files/2025-02/Sylvie%20Raver_0.png)
    
    [Samantha Schumm, PhD,](/experts/samantha-schumm-phd) [Lillian Parr,](/experts/lillian-parr) [Agnes Stephens,](/experts/agnes-stephens) and [Sylvie Raver, PhD](/experts/sylvie-raver-phd)
    
    27 Aug 2026
    
*   [Webinar](/content-hub/podcasts-webinars/webinars)
    
    ## [Ann Theodore Foundation Breakthrough Sarcoidosis Initiative, 2025–2026: Information Session](/content-hub/webinars/ann-theodore-foundation-breakthrough-sarcoidosis-initiative-2025-2026-information-session)
    
    22 Oct 2025
    
    The Ann Theodore Foundation, in partnership with the Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), is accepting optional letters of intent through Thursday October 23, 2025, for its fifth round of...
    
    [View Webinar](/content-hub/webinars/ann-theodore-foundation-breakthrough-sarcoidosis-initiative-2025-2026-information-session)
    
*   ![An abstract digital illustration representing sarcoidosis, featuring clusters of purple, irregular oval shapes containing smaller dark circles against a navy blue background, symbolizing granulomas.](/sites/default/files/styles/callout_content_425x240/public/2026-02/Sarcoidosis-metadata.jpg?itok=T0i7X2sB)
    
    [RFPs](/content-hub/rfps)
    
    ## [Request for Proposals: Ann Theodore Foundation Sarcoidosis Inhibitor of mTOR (SIM) Trial](/content-hub/rfps/request-proposals-ann-theodore-foundation-sarcoidosis-inhibitor-mtor-sim-trial)
    
    20 Feb 2026
    
    The Ann Theodore Foundation (ATF) is launching a new funding program to support the study of repurposed mechanistic target of rapamycin (mTOR) inhibitors as treatments for cutaneous sarcoidosis. This program will be executed in partnership...
    
    [Read Article](/content-hub/rfps/request-proposals-ann-theodore-foundation-sarcoidosis-inhibitor-mtor-sim-trial)
    
*   ![An abstract digital illustration representing sarcoidosis, featuring clusters of purple, irregular oval shapes containing smaller dark circles against a navy blue background, symbolizing granulomas.](/sites/default/files/styles/callout_content_425x240/public/2026-02/Sarcoidosis-metadata.jpg?itok=T0i7X2sB)
    
    [News Release](/content-hub/news-releases)
    
    ## [Milken Institute, Ann Theodore Foundation Launch New Grant to Support Clinical Trial for Potential Sarcoidosis Treatment](/content-hub/news-releases/milken-institute-ann-theodore-foundation-launch-new-grant-support-clinical-trial-potential)
    
    20 Feb 2026
    
    February 20, 2026 (Washington, DC)—The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), in partnership with the Ann Theodore Foundation (ATF), has launched a new funding program to support a future...
    
    [Read Article](/content-hub/news-releases/milken-institute-ann-theodore-foundation-launch-new-grant-support-clinical-trial-potential)
    
*   ![An abstract graphic of various blob like shapes of green, dark blue, light blue, and purple against a blue gradient background.](/sites/default/files/styles/callout_content_425x240/public/2025-06/uLMS-Giving-Smarter-Guide-Hero.jpg?itok=Wm58ksu9)
    
    [Report](/content-hub/research-and-reports/reports)
    
    ## [Uterine Leiomyosarcoma: A Giving Smarter Guide](/content-hub/research-and-reports/reports/uterine-leiomyosarcoma-giving-smarter-guide)
    
    24 Jun 2025
    
    This Giving Smarter Guide describes the current state of research, clinical practice, and treatment approaches for uterine leiomyosarcoma (uLMS) and identifies critical areas where philanthropy can significantly advance scientific knowledge...
    
    [Read Report](/content-hub/research-and-reports/reports/uterine-leiomyosarcoma-giving-smarter-guide)
    
    IM ![Photo of 1](/sites/default/files/2025-02/Caitlyn%20Barrett.png) ![Photo of 1](/sites/default/files/2025-02/Cara%20Altimus.png)
    
    [Ishtiaq Mawla,](/experts/ishtiaq-mawla) [Caitlyn Barrett, PhD,](/experts/caitlyn-barrett-phd) and [Cara Altimus, PhD](/staff/cara-altimus-phd)
    
    24 Jun 2025
    
*   ![misophonia hero image](/sites/default/files/styles/callout_content_425x240/public/2021-10/MicrosoftTeams-image%20%28105%29.png?itok=XuypGA-t)
    
    [RFPs](/content-hub/rfps)
    
    ## [Request for Proposals: Misophonia](/content-hub/rfps/request-proposals-misophonia)
    
    10 Dec 2021
    
    The Misophonia Research Fund is pleased to release the 2023 Request for Proposals. The General Grant Program RFP is soliciting research proposals that aim to characterize misophonia, develop objective methods to assess misophonia, or...
    
    [Read Article](/content-hub/rfps/request-proposals-misophonia)
    
*   ![](/sites/default/files/styles/callout_content_425x240/public/Misophonia%20-%20A%20Giving%20Smarter%20Guide%C2%A0_photo_0.jpeg?itok=BkTDm7pq)
    
    [Report](/content-hub/research-and-reports/reports)
    
    ## [Misophonia - A Giving Smarter Guide](/content-hub/research-and-reports/reports/misophonia-giving-smarter-guide)
    
    11 Oct 2020
    
    While some sounds can be annoying for most people, for a few, certain sounds like chewing, sniffling, or pen clicking can trigger an intense physical and emotional response. Those with this condition can experience increased heart rate...
    
    [Read Report](/content-hub/research-and-reports/reports/misophonia-giving-smarter-guide)
    
    JR ![Photo of 1](/sites/default/files/2025-02/Cara%20Altimus.png)
    
    James A. Randall and [Cara Altimus, PhD](/staff/cara-altimus-phd)
    
    11 Oct 2020
    
*   ![Abstract flowing shapes in coral, teal, orange, and cream colors with smooth organic curves](/sites/default/files/styles/callout_content_425x240/public/2026-05/Anxiety%20Giving%20Smarter%20Guide_hero.jpg?itok=fZi_FHks)
    
    [Report](/content-hub/research-and-reports/reports)
    
    ## [Anxiety: A Giving Smarter Guide](/content-hub/research-and-reports/reports/anxiety-giving-smarter-guide)
    
    3 May 2026
    
    Anxiety is a natural and adaptive emotion that promotes vigilance against potential threats. However, anxiety that persists or is disproportionate to actual risk becomes dysfunctional and can impair daily functioning.
    
    [Read Report](/content-hub/research-and-reports/reports/anxiety-giving-smarter-guide)
    
    IM ![Photo of 1](/sites/default/files/2025-12/Alison%20Huang.png) ![Photo of 1](/sites/default/files/2025-05/Lillian%20Parr.png) ![Photo of 1](/sites/default/files/2025-02/Sylvie%20Raver_0.png)
    
    [Ishtiaq Mawla,](/experts/ishtiaq-mawla) [Alison Huang, PhD,](/staff/alison-huang-phd) [Lillian Parr,](/experts/lillian-parr) and [Sylvie Raver, PhD](/experts/sylvie-raver-phd)
    
    3 May 2026